金固股份：10月24日召开董事会会议

Group 1 - The core point of the article is that Jingu Co., Ltd. held its 13th meeting of the 6th board of directors on October 24, 2025, to discuss amendments to the company's articles of association [1] - For the first half of 2025, Jingu Co., Ltd.'s revenue composition was as follows: automotive parts manufacturing accounted for 65.51%, steel trading accounted for 27.18%, and other businesses accounted for 7.31% [1] - As of the report date, Jingu Co., Ltd. has a market capitalization of 10 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated $80 billion in overseas licensing this year, highlighting the hot secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]